Evaluation of Treatment With Trans-resveratrol, Folic Acid, Vitamin D, Vitamin B12 and B6 in Men With Infertility
Evaluation of Treatment With Trans-resveratrol, Folic Acid, Vitamin D, Vitamin B12 and B6 in Men With Infertility
The objective of this study is to evaluate the impact of the Genante(TM) on the spermiogram parameters in infertile male patients
This is a single-centre prospective observational study. Twenty infertile male patients.
Inclusion criteria are:
Age:18-50 years oligozoospermia: < 5 million spermatozoa/mL; asthenozoospermia: < 32% progressive motile spermatozoa; teratozoospermia: < 4% normal forms.
Esclusion criteria:
Patients with azoospermia, who smoke, use drugs, drugs with proven fertility toxicity, exposed to any environmental or occupational toxic substances, radiation or heat; with orchitis secondary to mumps, sexually transmitted diseases, history of cryptorchidism, previous testicular torsion, genitourinary anomalies, alterations of the epididymis or deferens; and inguinal surgery
Pretreatment evaluation included:
Semen analysis Hormonal determinations:follicle-stimulating hormone (FSH) and luteinising hormone (LH) total Testosterone Total,estradiol, prolactina, 25-OH-Vitamin D3); scrotal ultrasound prostatic transrectal ultrasound
Outocmes measures (baseline, at 1 and 6 months):
Inclusion Criteria:
Exclusion Criteria:
elisabetta.costantini@unipg.it3283620614
ester.illiano@inwind.it3283620614